PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19887493-5 2010 Western blot analysis showed that PDGF-BB-induced phosphorylation of Akt, p70S6K, and p38 was inhibited by piceatannol, but not resveratrol. 3,3',4,5'-tetrahydroxystilbene 107-118 mitogen-activated protein kinase 14 Homo sapiens 86-89 22705645-6 2012 Piceatannol treatment induced p38 MAPK phosphorylation but inactivation of Akt and ERK. 3,3',4,5'-tetrahydroxystilbene 0-11 mitogen-activated protein kinase 14 Homo sapiens 30-33 20580678-0 2010 Piceatannol induces Fas and FasL up-regulation in human leukemia U937 cells via Ca2+/p38alpha MAPK-mediated activation of c-Jun and ATF-2 pathways. 3,3',4,5'-tetrahydroxystilbene 0-11 mitogen-activated protein kinase 14 Homo sapiens 85-93 20580678-2 2010 Piceatannol-induced apoptotic death of human leukemia U937 cells was characterized by increase in intracellular Ca(2+) concentration ([Ca(2+)]i), ERK inactivation, p38 MPAK activation, degradation of procaspase-8 and production of t-Bid. 3,3',4,5'-tetrahydroxystilbene 0-11 mitogen-activated protein kinase 14 Homo sapiens 164-167 20580678-5 2010 Abolition of piceatannol-induced increase in [Ca(2+)]i abrogated p38 MAPK activation and up-regulation of Fas and FasL expression, but restored ERK activation and viability of piceatannol-treated cells. 3,3',4,5'-tetrahydroxystilbene 13-24 mitogen-activated protein kinase 14 Homo sapiens 65-68 20580678-6 2010 Suppression of p38alpha MAPK or transfection of constitutively active MEK1 abolished piceatannol-induced Fas and FasL up-regulation. 3,3',4,5'-tetrahydroxystilbene 85-96 mitogen-activated protein kinase 14 Homo sapiens 15-23 20580678-7 2010 Piceatannol treatment repressed ERK-mediated c-Fos phosphorylation but evoked p38alpha MAPK-mediated c-Jun and ATF-2 phosphorylation. 3,3',4,5'-tetrahydroxystilbene 0-11 mitogen-activated protein kinase 14 Homo sapiens 78-86 20580678-9 2010 Taken together, our data indicate that Fas/FasL up-regulation in piceatannol-treated U937 cells is elicited by Ca(2+)/p38alpha MAPK-mediated activation of c-Jun and ATF-2, and suggest that autocrine Fas-mediated apoptotic mechanism is involved in piceatannol-induced cell death. 3,3',4,5'-tetrahydroxystilbene 65-76 mitogen-activated protein kinase 14 Homo sapiens 118-126 20580678-9 2010 Taken together, our data indicate that Fas/FasL up-regulation in piceatannol-treated U937 cells is elicited by Ca(2+)/p38alpha MAPK-mediated activation of c-Jun and ATF-2, and suggest that autocrine Fas-mediated apoptotic mechanism is involved in piceatannol-induced cell death. 3,3',4,5'-tetrahydroxystilbene 247-258 mitogen-activated protein kinase 14 Homo sapiens 118-126 14691575-8 2004 How-ever, phosphorylation of p38MAPK was prevented by the tyro-sine kinase Syk inhibitor piceatannol. 3,3',4,5'-tetrahydroxystilbene 89-100 mitogen-activated protein kinase 14 Homo sapiens 29-36 12038794-6 2002 Both 8-iso-PGF2alpha and U46619-induced p38 MAP kinase phosphorylation in suspended platelets and this was inhibited by piceatannol, indicating that Syk activation occurs upstream of p38 MAP kinase phosphorylation. 3,3',4,5'-tetrahydroxystilbene 120-131 mitogen-activated protein kinase 14 Homo sapiens 40-43 30066852-9 2018 Combined treatment with resveratrol and piceatannol also decreased tumor cell survival as indicated by the upregulation of the DNA damaging marker, gammaH2AX, the cleavage of caspase 3, the downregulation of the survival markers, p38-MAPK/c-Myc, and G1-to-S cell cycle arrest. 3,3',4,5'-tetrahydroxystilbene 40-51 mitogen-activated protein kinase 14 Homo sapiens 230-233